SOFIA (Bulgaria), December 9 (SeeNews) - Bulgarian drug maker Sopharma [BUL:3JR] said on Wednesday that its CEO Ognyan Donev acquired 60,347 shares in the company through deals priced at 3.03 levs ($1.87/1.55 euro) per share on December 8.